DBD stock: buy or sell?
November 19th, 2019
Diebold Nixdorf, Incorporated provides connected commerce services, software, and technology for financial, commercial, and industrial customers.
Should I buy DBD stock?Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Trading strategies are meant for helping you in the decision process of what stocks to choose and when is the best moment to buy them. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
Currently, Diebold Nixdorf stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Diebold Nixdorf stock a buy?
Banks and financial institutions publish stock ratings everyday.At Stocks2.com, we collected 2 ratings published for DBD stock in the last month.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-2-14||JPMorgan Chase & Co.||n/a||Sell|
DBD stock analysis
Shares of Diebold Nixdorf closed today at $7.85 and decreased a bad -1.13%.
Diebold Nixdorf decreased a bad -1.13% and closed at $7.85. Since price and SMA200d lines crossed down on October 8th, DBD fell $-1.94 per share (-19.82%).
Diebold Nixdorf slipped a horrible -3.56% this week. Late October DBD collapsed a frightening -28.88% in just one week. Early November DBD boosted an astounding 10.10% in just one week.
Since SMA20w and SMA40w crossed up early April, DBD price slid a -29.09%. Since price and SMA40w lines crossed up by mid February, DBD climbed $2.84 (56.69%).
DBD stock price history
DBD stock went public on December 31st, 1981 with a price of $2.071. Since then, DBD stock grew a 279.20%, with a yearly average of 7.50%. If you had invested right after DBD's IPO a $1,000 in DBD stock in 1981, it would worth $2,792.00 today.
1: Adjusted price after possible price splits or reverse-splits.
DBD stock historical price chart
DBD stock reached 52-week highs on July at $14.66, and all-time highs 2005-04-07 with a price of 38.51.
DBD stock price target is $7.00Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. Currently, only 1 price forecast for Diebold Nixdorf stock was posted in the last month:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-2-14||JPMorgan Chase & Co.||Set Price Target||n/a||$7.00||-|
Financials and fundamental analysis
Earnings date and Earnings per ShareSince February, when Diebold Nixdorf posted its last earnings report, it . As soon as we get its actual EPS from the earnings report, we will extend this report.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, Diebold Nixdorf annual turnover remained stable a bad -0.67% to $4,578.60 million USD from $4,609.30 marked in 2017. However, its income margin (compared to revenues) dropped to -12.42%, that is $-568.70 million.
|2013||$2,860 M||-||$-181.61 M-6.3%||-|
|2014||$3,051 M||6.68%||$114 M3.8%||-163.00%|
|2015||$2,419 M||-20.71%||$74 M3.0%||-35.59%|
|2016||$3,316 M||37.08%||$-33.00 M-1.0%||-144.78%|
|2017||$4,609 M||38.99%||$-241.50 M-5.2%||631.82%|
|2018||$4,579 M||-0.67%||$-568.70 M-12.4%||135.49%|
Quarterly financial resultsDiebold Nixdorf posted $1,289.80 M in sales for 2018-Q4, a 15.26% improvement compared to previous quarter. Reported quarter earnings marked $-145.50 M with a profit margin of -11.28%. Profit margin rose a 7.72% compared to previous quarter when profit margin was -19.00%. When comparing revenues to same quarter last year, Diebold Nixdorf sales marked a nice growth and grew a 3.19%. Looking back to recent quarterly results, Diebold Nixdorf posted 3 negative quarters in a row.
|2017-Q2||$1,130 M||-||$-30.60 M-2.7%||-|
|2017-Q3||$1,123 M||-0.65%||$-35.40 M-3.2%||15.69%|
|2017-Q4||$1,250 M||11.33%||$-106.40 M-8.5%||200.56%|
|2018-Q1||$1,064 M||-14.86%||$-70.90 M-6.7%||-33.36%|
|2018-Q2||$1,106 M||3.89%||$-138.50 M-12.5%||95.35%|
|2018-Q3||$1,119 M||1.21%||$-212.60 M-19.0%||53.50%|
|2018-Q4||$1,290 M||15.26%||$-145.50 M-11.3%||-31.56%|
|2019-Q1||$1,028 M||-20.29%||$-132.70 M-12.9%||-8.80%|
Diebold Nixdorf ownershipWhen you are planning to buy a company, it's worth to review its ownership structure.
Diebold Nixdorf shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 2.39% of all shares.
Bearish positions for DBD stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to Diebold Nixdorf:
|Market cap||$602.8 M||$4.5 B||$4.3 B||$505.5 M||$743.2 M|
|Total shares||76.8 M||50.0 M||129.5 M||16.4 M||170.9 M|
|Float shares||75.6 M||49.3 M||119.5 M||8.5 M||169.4 M|
|- Institutional holdings (%)||99.2%||105.1%||98.8%||59.5%||74.1%|
|- Insider holdings (%)||2.4%||1.1%||1.3%||33.8%||0.5%|
|Shares in short selling||0.0%||0.0%||0.0%||0.0%||0.0%|
|Tuesday, November 19th, 2019|
|Day range||$7.71 - $8.01|
|Average true range||$0.47|
|50d mov avg||$9.90|
|100d mov avg||$10.76|
|200d mov avg||$10.33|
Diebold Nixdorf performancePerformance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. We picked Brink's, NCR, PAR Technology, Pitney Bowes and USA Technologies as the bechmarking frame for Diebold Nixdorf stock.